Related Experiment Video
Updated: May 25, 2025
07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
26.4K
A Review on Melanoma Brain Metastases
Sabi Shrestha1, Charles M Cook2, Jay Parekh3
1Department of Radiation Oncology, Mays Cancer Center, UT Health San Antonio, San Antonio, USA.
Current Pharmaceutical Design
|February 28, 2025
Summary
Melanoma brain metastases (MBM) present a poor prognosis, but recent advances in targeted therapies, immunotherapies, and stereotactic radiosurgery (SRS) are improving patient survival. This overview discusses current and emerging MBM treatments and future research directions.
Area of Science:
- Oncology
- Neuro-oncology
- Cancer Research
Background:
- Melanoma brain metastases (MBM) are a significant clinical challenge with poor patient prognosis.
- Understanding the molecular basis of MBM has advanced significantly.
- Existing treatments for MBM offer limited efficacy.
Purpose of the Study:
- To provide a comprehensive overview of current and emerging treatment strategies for MBM.
- To highlight recent advancements in MBM therapy.
- To identify future research and clinical practice directions for MBM.
Main Methods:
- Literature review of recent studies on MBM treatment.
- Analysis of targeted therapies, immunotherapies, and stereotactic radiosurgery (SRS) for MBM.
- Synthesis of data on novel therapeutic modalities and their potential impact.
Main Results:
- Significant progress in understanding MBM molecular mechanisms.
- Demonstrated improvements in patient survival with targeted therapies, immunotherapies, and SRS.
- Emerging treatment modalities show promise for enhanced efficacy.
Conclusions:
- Current treatment landscape for MBM shows significant progress.
- Advances in targeted therapy, immunotherapy, and SRS have improved outcomes.
- Future research should focus on novel approaches and personalized medicine for MBM.
